BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37046606)

  • 1. The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT).
    Sohn EJ; Goralsky JA; Shay JW; Min J
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
    Sobinoff AP; Pickett HA
    Trends Genet; 2017 Dec; 33(12):921-932. PubMed ID: 28969871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.
    Hou K; Yu Y; Li D; Zhang Y; Zhang K; Tong J; Yang K; Jia S
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks.
    Zhang JM; Zou L
    Cell Biosci; 2020; 10():30. PubMed ID: 32175073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers.
    Lu R; Pickett HA
    Open Biol; 2022 Mar; 12(3):220011. PubMed ID: 35259951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT).
    Sun H; Chen G; Guo B; Lv S; Yuan G
    J Cancer; 2023; 14(3):417-433. PubMed ID: 36860927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALT: A Multi-Faceted Phenomenon.
    Sommer A; Royle NJ
    Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 32012790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
    Kent T; Gracias D; Shepherd S; Clynes D
    Front Oncol; 2019; 9():1518. PubMed ID: 32039009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
    Gocha ARS; Harris J; Groden J
    Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.
    Abid HZ; McCaffrey J; Raseley K; Young E; Lassahn K; Varapula D; Riethman H; Xiao M
    BMC Genomics; 2020 Jul; 21(1):485. PubMed ID: 32669102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCNA, a focus on replication stress and the alternative lengthening of telomeres pathway.
    Shen M; Young A; Autexier C
    DNA Repair (Amst); 2021 Apr; 100():103055. PubMed ID: 33581499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative paths to telomere elongation.
    Lee JJ; Lee J; Lee H
    Semin Cell Dev Biol; 2021 May; 113():88-96. PubMed ID: 33293233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
    Gao J; Pickett HA
    Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New twists to the ALTernative endings at telomeres.
    Bhargava R; Lynskey ML; O'Sullivan RJ
    DNA Repair (Amst); 2022 Jul; 115():103342. PubMed ID: 35588569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms that drive telomere maintenance and recombination in human cancers.
    Sobinoff AP; Pickett HA
    Curr Opin Genet Dev; 2020 Feb; 60():25-30. PubMed ID: 32119936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
    Min J; Wright WE; Shay JW
    Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.